Glycine

Glycine

SCHEMBL599169

Cl.Cl.Cl.Cl.NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].NCC(=O)[O-].[Al+3].[Zr+4]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA4 P22748 3/20 0.41
GLRA1 P23415 1/20 0.41
SLC6A9 P48067 1/20 0.41
OR51E2 Q9H255 1/20 0.41
CASP1 P29466 1/20 0.37
FFAR3 O14843 2/20 0.33
HDAC3 O15379 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
MEN1 O00255 1/20 0.32
LDHA P00338 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
GABRR1 P24046 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL3267690 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL9019048 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL699842 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL5472175 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL5478239 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL3028174 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL700064 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL1933545 1.00 CA4 (0.41) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL10433486 0.97 CA4 (0.39) CA4GLRA1SLC6A9OR51E2CASP1
Glycine SCHEMBL2025189 0.96 CA4 (0.44) CA4GLRA1SLC6A9OR51E2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283179-B1 SOLID SKIN CARE EMULSION COMPRISING SOLID AND LIQUID LIPIDS BEIERSDORF AG (DE) 2021-01-27 EP claimed
US-20200121566-A1 Methods of Making Solid Stick Antiperspirant Compositions PROCTER & GAMBLE (US) 2020-04-23 US claimed
CN-110114052-A Extruded antiperspirant compositions having improved efficacy 高露洁-棕榄公司 2019-08-09 CN claimed
EP-2900203-B1 METHODS OF MAKING SOLID STICK ANTIPERSPIRANT COMPOSITIONS PROCTER & GAMBLE (US) 2018-09-12 EP claimed
EP-2900199-B1 SOLID STICK ANTIPERSPIRANT COMPOSITIONS PROCTER & GAMBLE (US) 2018-09-05 EP claimed
US-10016343-B2 Solid stick antiperspirant compositions THE PROCTER & GAMBLE COMPANY (US) 2018-07-10 US claimed
EP-3283179-A1 SOLID SKIN CARE EMULSION COMPRISING SOLID AND LIQUID LIPIDS Beiersdorf AG (DE) 2018-02-21 EP claimed
CN-102470080-B Catalysed dye systems 利兹大学 2017-08-29 CN claimed
US-9724543-B2 Antiperspirant products comprising active antiperspirant compounds surface treated with hydrophobizing agents and methods for manufacturing the same Henkel IP & Holding GmbH (DE) 2017-08-08 US claimed
WO-2016155867-A1 SOLID SKIN CARE EMULSION COMPRISING SOLID AND LIQUID LIPIDS BEIERSDORF AG (DE) 2016-10-06 WO claimed
US-20140260103-A1 Methods of Making Solid Stick Antiperspirant Compositions THE PROCTER & GAMBLE COMPANY (US) 2014-09-18 US claimed
US-20140271515-A1 Solid Stick Antiperspirant Compositions THE PROCTER & GAMBLE COMPANY (US) 2014-09-18 US claimed
US-20120070393-A1 ANTIPERSPIRANT STICK COMPOSITION COTY GERMANY GMBH (DE) 2012-03-22 US claimed
US-20120039968-A1 ANTIPERSPIRANT PRODUCTS COMPRISING ACTIVE ANTIPERSPIRANT COMPOUNDS SURFACE TREATED WITH HYDROPHOBIZING AGENTS AND METHODS FOR MANUFACTURING THE SAME THE DIAL CORPORATION (US) 2012-02-16 US claimed
EP-2208494-A1 Antiperspirant stick composition Coty Deutschland GmbH (DE) 2010-07-21 EP claimed
EP-1521568-A1 NON-IRRITATING ANTIPERSPIRANT COMPOSITIONS CONTAINING ACIDIC ANTIPERSPIRANT ACTIVE THE PROCTER & GAMBLE COMPANY (US) 2005-04-13 EP claimed
US-6835373-B2 A particulate antiperspirant active having a metal to chloride molar ratio of <= to about 1.3, a volatile solvent, a low surface tension nonvolatile solvent and a suspending agent THE PROCTER & GAMBLE COMPANY 2004-12-28 US claimed
WO-2004006877-A1 NON-IRRITATING ANTIPERSPIRANT COMPOSITIONS CONTAINING ACIDIC ANTIPERSPIRANT ACTIVE THE PROCTER & GAMBLE COMPANY (US) 2004-01-22 WO claimed
US-20040009133-A1 Non-irritating antiperspirant compositions containing acidic antiperspirant active THE PROCTER & GAMBLE COMPANY 2004-01-15 US claimed
US-4774079-A BUFFERS, ESPECIALLY GLYCINE, ACIDITY BRISTOL-MYERS COMPANY (US) 1988-09-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009133-A1 Non-irritating antiperspirant compositions containing acidic antiperspirant active SIGMAR1, PTPN6, PTPN14 CA4 877/4885GLRA1 767/4885SLC6A9 964/4885
US-10016343-B2 Solid stick antiperspirant compositions SUPT16H, SSRP1, U2SURP CA4 3313/4885GLRA1 3241/4885SLC6A9 1706/4885
US-20140271515-A1 Solid Stick Antiperspirant Compositions SUPT16H, SSRP1, U2SURP CA4 3313/4885GLRA1 3241/4885SLC6A9 1706/4885
US-20140260103-A1 Methods of Making Solid Stick Antiperspirant Compositions U2SURP, SUPT16H, RNGTT CA4 3053/4885GLRA1 3511/4885SLC6A9 1549/4885
US-20200121566-A1 Methods of Making Solid Stick Antiperspirant Compositions U2SURP, SUPT16H, RNGTT CA4 3053/4885GLRA1 3511/4885SLC6A9 1549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.